Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021246
Company: ROCHE
Company: ROCHE
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 12MG BASE/ML | FOR SUSPENSION;ORAL | Discontinued | None | No | No |
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 12/14/2000 | ORIG-1 | Approval | Type 3 - New Dosage Form | PRIORITY |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21246LBL.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21246ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-246_Tamiflu.cfm |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 08/10/2021 | SUPPL-55 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/021246Orig1s055ltr.pdf |
| 08/02/2019 | SUPPL-54 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021087s071,021246s054lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021087Orig1s071, 021246Orig1s054ltr.pdf | |
| 12/12/2018 | SUPPL-53 | Labeling-Patient Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s070lbl, 021246s053lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021087s070ltr, 021246s053ltr.pdf | |
| 04/04/2018 | SUPPL-52 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s069,021246s052lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021087Orig1s069,021246Orig1s052ltr.pdf | |
| 06/20/2016 | SUPPL-51 | Labeling-Package Insert, Labeling-Patient Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021087s068,021246s051lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021087Orig1s068,021246Orig1s051ltr.pdf | |
| 03/16/2015 | SUPPL-50 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 10/14/2014 | SUPPL-48 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s065,021246s048lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021087Orig1s065,021246Orig1s048ltr.pdf | |
| 05/30/2014 | SUPPL-47 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s064,021246s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021087Orig1s064,021246Orig1s047ltr.pdf | |
| 02/07/2013 | SUPPL-46 | Manufacturing (CMC) |
Label is not available on this site. |
||
| 12/21/2012 | SUPPL-45 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021246s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021087Orig1s062,021246Orig1s045ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/021246Orig1s045_021087Orig1s062_tamiflu_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2012/021087Orig1s062021246Orig1s045SumR.pdf | |
| 01/29/2013 | SUPPL-44 | Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021087s061,021246s044lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021087Orig1s061,021246Orig1s044ltr.pdf | |
| 11/26/2014 | SUPPL-43 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s060,021246s043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021087Orig1s060,021246Orig1s043ltr.pdf | |
| 08/16/2012 | SUPPL-42 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021087s059,021246s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021087Orig1s059,021246Orig1s042ltr.pdf | |
| 02/07/2011 | SUPPL-40 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021246s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021087s057,021246s040ltr.pdf | |
| 03/21/2011 | SUPPL-39 | Labeling |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s056_021246s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021087s056,021246s039ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/021246Orig1s039.pdf | |
| 11/05/2010 | SUPPL-38 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021246s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021087s055,021246s038ltr.pdf | |
| 02/22/2010 | SUPPL-35 | Efficacy-New Dosing Regimen |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s048s049,021246s034s035lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021087s048s049,021246s034s035ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/021246Orig1s035.pdf | |
| 02/22/2010 | SUPPL-34 | Labeling |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s048s049,021246s034s035lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021087s048s049,021246s034s035ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/021246Orig1s034.pdf | |
| 09/25/2008 | SUPPL-33 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021087s047, 021246s033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021087s047,021246s033ltr.pdf | |
| 02/23/2009 | SUPPL-32 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021246s032ltr.pdf |
| 12/15/2010 | SUPPL-31 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s045,021246s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021087s045,021246s031ltr.pdf | |
| 01/17/2008 | SUPPL-30 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021087s042,021246s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021087s042,021246s030ltr.pdf | |
| 10/05/2007 | SUPPL-28 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021087s041,021246s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021087s041, 021246s028ltr.pdf | |
| 07/02/2007 | SUPPL-27 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021087s040, 021246s027_LBL.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021087s040, 021246s027_LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021246Orig1s027.pdf | |
| 03/26/2007 | SUPPL-26 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021087s039_021246s026ltr.pdf |
| 03/22/2007 | SUPPL-25 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021246s025_021087s038ltr.pdf |
| 03/12/2007 | SUPPL-24 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021087s037_021246s024ltr.pdf |
| 12/14/2006 | SUPPL-23 | Manufacturing (CMC)-Manufacturing Process |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021246s023ltr.pdf |
| 02/01/2007 | SUPPL-22 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021087s035_021246s022ltr.pdf |
| 11/13/2006 | SUPPL-21 | Labeling |
Label (PDF)
Letter (PDF) Patient Package Insert (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021246s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021087s033, 021246s021LTR.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021246s021ppi.pdf | |
| 06/23/2006 | SUPPL-20 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021087s031_021246s020ltr.pdf |
| 12/01/2005 | SUPPL-19 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021087s029_021246s019ltr.pdf |
| 10/14/2005 | SUPPL-18 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021087s028_021246s018ltr.pdf |
| 12/21/2005 | SUPPL-17 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) Patient Package Insert (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021246s017_021087s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021246s017,021087s030rev2.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021246s017,021087s30ppi.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021246Orig1s017.pdf | |
| 05/19/2005 | SUPPL-16 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021087s024_021246s016ltr.pdf |
| 01/18/2005 | SUPPL-14 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021087s021_021246s014ltr.pdf |
| 10/19/2004 | SUPPL-13 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021087s020_021246s013ltr.pdf |
| 08/12/2004 | SUPPL-12 | Manufacturing (CMC)-Facility |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021087s019_021246s012ltr.pdf |
| 04/26/2004 | SUPPL-11 | Manufacturing (CMC) |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/021087s018_021246s011ltr.pdf |
| 06/24/2004 | SUPPL-10 | Labeling |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21087slr016,21246slr010_Tamiflu_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21087slr016,21246slr010ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021087_S016_021246s010TamifluTOC.cfm | |
| 02/14/2003 | SUPPL-8 | Efficacy-Accelerated Approval Confirmatory Study |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/021087s014_021246s008ltr.pdf |
| 04/26/2002 | SUPPL-7 | Labeling |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21087S10lbl_update.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21087s010update.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021087_S010_021246s007_TamifluTOC.cfm | |
| 03/04/2002 | SUPPL-6 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/021246_S006_TamifluTOC.cfm |
| 11/05/2001 | SUPPL-4 | Labeling |
Label (PDF)
Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21087s9lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021087_S009_021246s004TamifluTOC.cfm | |
| 07/24/2001 | SUPPL-3 | Labeling |
Label (PDF)
Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21246s3lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021087_S008_021246s003_TamifluTOC.cfm | |
| 07/05/2001 | SUPPL-2 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021246_S002_TamifluTOC.cfm |
| 07/24/2001 | SUPPL-1 | Labeling |
Label (PDF)
Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21246s1lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/021087_s005s006_021246s001_TamifluTOC.cfm |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 08/02/2019 | SUPPL-54 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021087s071,021246s054lbl.pdf | |
| 12/12/2018 | SUPPL-53 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s070lbl, 021246s053lbl.pdf | |
| 12/12/2018 | SUPPL-53 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s070lbl, 021246s053lbl.pdf | |
| 04/04/2018 | SUPPL-52 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s069,021246s052lbl.pdf | |
| 06/20/2016 | SUPPL-51 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021087s068,021246s051lbl.pdf | |
| 06/20/2016 | SUPPL-51 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021087s068,021246s051lbl.pdf | |
| 11/26/2014 | SUPPL-43 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s060,021246s043lbl.pdf | |
| 10/14/2014 | SUPPL-48 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s065,021246s048lbl.pdf | |
| 05/30/2014 | SUPPL-47 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021087s064,021246s047lbl.pdf | |
| 01/29/2013 | SUPPL-44 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021087s061,021246s044lbl.pdf | |
| 12/21/2012 | SUPPL-45 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021246s045lbl.pdf | |
| 08/16/2012 | SUPPL-42 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021087s059,021246s042lbl.pdf | |
| 03/21/2011 | SUPPL-39 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021087s056_021246s039lbl.pdf | |
| 02/07/2011 | SUPPL-40 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021246s040lbl.pdf | |
| 12/15/2010 | SUPPL-31 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s045,021246s031lbl.pdf | |
| 11/05/2010 | SUPPL-38 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021246s038lbl.pdf | |
| 02/22/2010 | SUPPL-35 | Efficacy-New Dosing Regimen | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s048s049,021246s034s035lbl.pdf | |
| 02/22/2010 | SUPPL-34 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021087s048s049,021246s034s035lbl.pdf | |
| 09/25/2008 | SUPPL-33 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021087s047, 021246s033lbl.pdf | |
| 01/17/2008 | SUPPL-30 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021087s042,021246s030lbl.pdf | |
| 10/05/2007 | SUPPL-28 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021087s041,021246s028lbl.pdf | |
| 07/02/2007 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021087s040, 021246s027_LBL.pdf | |
| 07/02/2007 | SUPPL-27 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021087s040, 021246s027_LBL.pdf | |
| 11/13/2006 | SUPPL-21 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021246s021lbl.pdf | |
| 12/21/2005 | SUPPL-17 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021246s017_021087s030lbl.pdf | |
| 06/24/2004 | SUPPL-10 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21087slr016,21246slr010_Tamiflu_lbl.pdf | |
| 04/26/2002 | SUPPL-7 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21087S10lbl_update.pdf | |
| 11/05/2001 | SUPPL-4 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21087s9lbl.pdf | |
| 07/24/2001 | SUPPL-3 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21246s3lbl.pdf | |
| 07/24/2001 | SUPPL-1 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21246s1lbl.pdf | |
| 12/14/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21246LBL.pdf |
TAMIFLU
FOR SUSPENSION;ORAL; EQ 6MG BASE/ML
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 212784 | AJANTA PHARMA LTD |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 208823 | ALVOGEN |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 210186 | AMNEAL PHARMS NY |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 218131 | AUROBINDO PHARMA LTD |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 215538 | EPIC PHARMA LLC |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 209590 | HETERO LABS LTD V |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 212858 | INVAGEN PHARMS |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 208347 | LUPIN |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 215313 | MSN |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 217303 | ORYZA |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 211894 | STRIDES PHARMA |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 213594 | SUNSHINE |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 211125 | TEVA PHARMS USA |
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | No | AB | 209113 | ZYDUS PHARMS |
| TAMIFLU | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL | Prescription | Yes | AB | 021246 | ROCHE |